Pharmacogenetics of asthma
Authors:
- Gerard H. KoppelmanGKGerard H. Koppelman
- 1 January 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 23 (1) , 12-20
Abstract
Although currently available drugs to treat asthma are effective in most patients, a proportion of patients do not respond or experience side-effects; which is partly genetically determined. Pharmacogenetics is the study of how genetic variations influence drug response. In this review, we summarize prior results and recent studies in pharmacogenetics to determine if we can use genetic profiles for personalized treatment of asthma. The field of pharmacogenetics has moved from candidate gene studies in single populations toward genome-wide association studies and meta-analysis of multiple studies. New technologies have been used to enrich results, and an expanding number of genetic loci have been associated with therapeutic responses to asthma drugs. Prospective, genotype-stratified treatment studies have been conducted for β2-agonists, showing attenuated response in children carrying the Arg16 variant in the β2-adrenoreceptor gene. Although there has been much progress, many findings have not been replicated and currently known genetic loci only account for a fraction of variability in drug response. More research is necessary to translate into clinical practice. A polygenic predictive approach integrated in complex networks with other 'omics' technologies could aid to achieve this goal. Finally, to change clinical practice, studies that compare precision medicine with traditional medicine are needed.Keywords
This publication has 54 references indexed in Scilit:
- Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatmentJournal of Allergy and Clinical Immunology, 2016
- Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With AsthmaJAMA, 2015
- A summary of the new GINA strategy: a roadmap to asthma controlEuropean Respiratory Journal, 2015
- Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapiesJournal of Internal Medicine, 2015
- A New Initiative on Precision MedicineNew England Journal of Medicine, 2015
- Tailored second-line therapy in asthmatic children with the Arg16 genotypeClinical Science, 2013
- Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response GenePLOS Genetics, 2012
- Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterolJournal of Allergy and Clinical Immunology, 2009
- Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trialThe Lancet, 2009
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialThe Lancet, 2004